CytomX Therapeutics, Inc.
NASDAQ:CTMX
1.09 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 17.171 | 193.65 | 205.53 | 191.859 | 188.425 | 247.577 | 177.548 | 104.645 | 59.822 | 64.396 | 8.703 |
| Short Term Investments
| 157.338 | 0 | 99.696 | 124.26 | 107.72 | 188.55 | 196.562 | 77.293 | 126.889 | 0 | 0 |
| Cash and Short Term Investments
| 174.509 | 193.65 | 305.226 | 316.119 | 296.145 | 436.127 | 374.11 | 181.938 | 186.711 | 64.396 | 8.703 |
| Net Receivables
| 3.432 | 35.986 | 0.79 | 0.798 | 0.013 | 0.097 | 10.139 | 2.313 | 0.744 | 1.875 | 0.237 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 |
| Other Current Assets
| 4.995 | 7.466 | 4.285 | 7.096 | 7.177 | 9.251 | 4.352 | 3.896 | 2.299 | 0.482 | 0.226 |
| Total Current Assets
| 182.936 | 237.102 | 310.301 | 324.013 | 303.335 | 445.475 | 388.601 | 188.147 | 189.754 | 66.853 | 9.266 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 16.178 | 21.021 | 25.322 | 29.445 | 32.754 | 6.934 | 4.218 | 4.392 | 3.481 | 3.018 | 2.07 |
| Goodwill
| 0.949 | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 |
| Intangible Assets
| 0.729 | 0.875 | 1.021 | 1.167 | 1.312 | 1.458 | 1.604 | 1.75 | 1.75 | 1.75 | 1.75 |
| Goodwill and Intangible Assets
| 1.678 | 1.824 | 1.97 | 2.116 | 2.261 | 2.407 | 2.553 | 2.699 | 2.699 | 2.699 | 2.699 |
| Long Term Investments
| 0.917 | 0.917 | 0.917 | 0.917 | 0.917 | 0.917 | 0.917 | 0.917 | 0.995 | 0 | 0 |
| Tax Assets
| 3.359 | 3.595 | 4.61 | 5.542 | -0.917 | 1.137 | 0.398 | 0.311 | 0.401 | 0 | 0 |
| Other Non-Current Assets
| 0.083 | -3.568 | -3.709 | -3.37 | 2.932 | 0.238 | 0.957 | 2.662 | -0.115 | 0.492 | 0.148 |
| Total Non-Current Assets
| 22.215 | 23.789 | 29.11 | 34.65 | 37.947 | 11.633 | 9.043 | 10.981 | 7.461 | 6.209 | 4.917 |
| Total Assets
| 205.151 | 260.891 | 339.411 | 358.663 | 341.282 | 457.108 | 397.644 | 199.128 | 197.215 | 73.062 | 14.183 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 1.458 | 2.809 | 2.818 | 2.996 | 4.158 | 5.132 | 4.205 | 6.596 | 4.697 | 1.919 | 0.93 |
| Short Term Debt
| 4.589 | 4.082 | 3.618 | 3.195 | 2.81 | 13.339 | 0 | 0 | 0 | 1.419 | 1.258 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 13.339 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 132.267 | 121.267 | 69.262 | 74.869 | 51.381 | 52.713 | 40.559 | 20.347 | 6.13 | 6.13 | 0.857 |
| Other Current Liabilities
| 17.599 | 24.45 | 30.618 | 19.864 | 27.241 | 26.724 | 16.383 | 8.824 | 4.912 | 1.695 | 1.127 |
| Total Current Liabilities
| 155.913 | 152.608 | 106.316 | 100.924 | 85.59 | 97.908 | 61.147 | 35.767 | 15.739 | 11.163 | 4.172 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 9.385 | 13.975 | 18.056 | 21.675 | 24.871 | -1.137 | -0.398 | 0 | 0 | 1.568 | 2.945 |
| Deferred Revenue Non-Current
| 80.048 | 180.059 | 125.66 | 186.261 | 178.858 | 225.267 | 264.704 | 83.803 | 54.703 | 60.833 | 4.643 |
| Deferred Tax Liabilities Non-Current
| 3.359 | 3.595 | 4.61 | 5.542 | 0 | 1.137 | 0.398 | 0.513 | 0.507 | 0.499 | 0.491 |
| Other Non-Current Liabilities
| 3.893 | -3.595 | -4.61 | -5.542 | 0.85 | 3.05 | 1.897 | 0.566 | 0.198 | 77.54 | 46.211 |
| Total Non-Current Liabilities
| 96.685 | 194.034 | 143.716 | 207.936 | 204.579 | 228.317 | 266.601 | 84.882 | 55.408 | 140.44 | 54.29 |
| Total Liabilities
| 252.598 | 346.642 | 250.032 | 308.86 | 290.169 | 326.225 | 327.748 | 120.649 | 71.147 | 151.603 | 58.462 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 457.108 | 397.644 | 199.128 | 197.215 | 76.896 | 44.862 |
| Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -723.448 | -722.879 | -533.724 | -450.115 | -417.23 | -314.981 | -219.465 | -176.366 | -117.466 | -78.138 | -43.881 |
| Accumulated Other Comprehensive Income/Loss
| 0.095 | 0.01 | -0.242 | -0.047 | 0.057 | -0.093 | -0.094 | -0.027 | -0.076 | -0.404 | -0.399 |
| Other Total Stockholders Equity
| 675.905 | 637.117 | 623.344 | 499.964 | 468.285 | -11.152 | -108.19 | 55.743 | 46.394 | -76.896 | -44.862 |
| Total Shareholders Equity
| -47.447 | -85.751 | 89.379 | 49.803 | 51.113 | 130.883 | 69.896 | 78.479 | 126.068 | -78.541 | -44.279 |
| Total Equity
| -47.447 | -85.751 | 89.379 | 49.803 | 51.113 | 130.883 | 69.896 | 78.479 | 126.068 | -78.541 | -44.279 |
| Total Liabilities & Shareholders Equity
| 205.151 | 260.891 | 339.411 | 358.663 | 341.282 | 457.108 | 397.644 | 199.128 | 197.215 | 73.062 | 14.183 |